| Literature DB >> 12470255 |
Christopher A Lepre1, Jeffrey Peng, Jasna Fejzo, Norzehan Abdul-Manan, Jennifer Pocas, Marc Jacobs, Xiaoling Xie, Jonathan M Moore.
Abstract
The SHAPES strategy combines nuclear magnetic resonance (NMR) screening of a library of small drug-like molecules with a variety of complementary methods, such as virtual screening, high throughput enzymatic assays, combinatorial chemistry, X-ray crystallography, and molecular modeling, in a directed search for new medicinal chemistry leads. In the past few years, the SHAPES strategy has found widespread utility in pharmaceutical research. To illustrate a variety of different implementations of the method, we will focus in this review on recent applications of the SHAPES strategy in several drug discovery programs at Vertex Pharmaceuticals.Mesh:
Substances:
Year: 2002 PMID: 12470255 DOI: 10.2174/1386207023329950
Source DB: PubMed Journal: Comb Chem High Throughput Screen ISSN: 1386-2073 Impact factor: 1.339